Francesco Giotta

11PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAboriginal and Torres Strait Islander theory of change models for healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1-Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy.

|Oct 29, 2025
CDK4/6 Inhibitors in Patients Aged 80 and Older with HR+/HER2- Metastatic Breast Cancer: A Real-World Multicenter Study.

Palma Fedele, Matteo Landriscina, Lucia Moraca

|Dec 17, 2024
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.

Palma Fedele, Matteo Landriscina, Lucia Moraca

|Nov 09, 2024
Knowledge and Misinformation About Breast Cancer Risk Factors, Symptoms, and Prevention Among Healthy and Affected Women: A Study on 2375 Italian Participants.

Luana Conte, Roberto Lupo, Alessia Lezzi

|Oct 26, 2024
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.

Palma Fedele, Matteo Landriscina, Lucia Moraca

|Aug 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.

Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto

Pageof 2

Frequent Collaborators

3 joint publications

Matteo Landriscina

2 joint publications

Gennaro Gadaleta-Caldarola

2 joint publications

Nicola Tinari

2 joint publications

Palma Fedele